SUFFRITTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 3.523
EU - Europa 2.757
AS - Asia 2.694
SA - Sud America 279
AF - Africa 65
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.334
Nazione #
US - Stati Uniti d'America 3.399
CN - Cina 938
GB - Regno Unito 718
SG - Singapore 695
IT - Italia 626
DE - Germania 259
BD - Bangladesh 235
HK - Hong Kong 229
SE - Svezia 203
BR - Brasile 196
RU - Federazione Russa 195
FR - Francia 148
VN - Vietnam 142
NL - Olanda 116
IN - India 114
IE - Irlanda 87
FI - Finlandia 81
CA - Canada 78
TR - Turchia 72
ES - Italia 65
JP - Giappone 60
UA - Ucraina 50
KR - Corea 47
DK - Danimarca 42
ID - Indonesia 39
AR - Argentina 33
CI - Costa d'Avorio 30
MX - Messico 27
PL - Polonia 23
AT - Austria 21
BE - Belgio 20
PT - Portogallo 20
UZ - Uzbekistan 17
CH - Svizzera 16
CO - Colombia 16
EU - Europa 15
TH - Thailandia 15
AE - Emirati Arabi Uniti 13
AU - Australia 11
CL - Cile 10
CZ - Repubblica Ceca 10
HU - Ungheria 10
IR - Iran 10
PH - Filippine 10
PE - Perù 9
PK - Pakistan 9
TW - Taiwan 9
ZA - Sudafrica 9
BG - Bulgaria 8
IQ - Iraq 8
MA - Marocco 7
SA - Arabia Saudita 7
JM - Giamaica 6
RO - Romania 6
EC - Ecuador 5
GR - Grecia 5
HR - Croazia 5
NP - Nepal 5
VE - Venezuela 5
AL - Albania 4
DZ - Algeria 4
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
RS - Serbia 4
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
SC - Seychelles 2
SI - Slovenia 2
SV - El Salvador 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 9.345
Città #
Southend 608
Singapore 414
Ashburn 361
Chandler 251
Milan 233
Dallas 217
Hong Kong 199
San Jose 186
Beijing 162
New York 140
Fairfield 121
Wilmington 109
Los Angeles 102
Houston 94
Santa Clara 94
Council Bluffs 92
Ann Arbor 86
Dublin 75
Seattle 73
Princeton 71
Frankfurt am Main 69
Redwood City 58
Woodbridge 56
Dearborn 54
Helsinki 54
Boardman 47
Hefei 46
Lauterbourg 45
Ho Chi Minh City 43
Buffalo 42
Munich 41
Hanoi 40
Tokyo 40
Bengaluru 39
Nanjing 39
Cambridge 37
Shanghai 35
Putian 34
Des Moines 31
Guangzhou 31
Abidjan 30
Jinan 30
Jakarta 29
Moscow 28
Mountain View 27
Toronto 25
Barcelona 24
Chicago 24
Istanbul 24
Mumbai 23
Fuzhou 22
Jacksonville 22
Columbus 21
Phoenix 20
São Paulo 20
Redmond 19
Rome 19
Seoul 18
Brussels 17
Chester 17
Shenyang 16
Changsha 15
Hangzhou 15
London 15
Nanchang 15
San Diego 15
Tianjin 15
Berlin 14
Buenos Aires 14
Denver 14
Fremont 14
Rio de Janeiro 14
Zhengzhou 14
Cangzhou 13
Orem 13
Ottawa 13
Somerville 13
Duncan 12
Lisbon 12
Serra 12
Chennai 11
Naples 11
Roxbury 11
Warsaw 11
Amsterdam 10
Bogotá 10
Haiphong 10
Napoli 10
Nuremberg 10
The Dalles 10
Vienna 10
Xiamen 10
Andover 9
Atlanta 9
Bangkok 9
Boston 9
Florence 9
Montreal 9
Philadelphia 9
Shenzhen 9
Totale 5.502
Nome #
Current and emerging biologics for the treatment of hereditary angioedema 768
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 370
A transcriptomics study of hereditary angioedema attacks 362
Remittent C1-inhibitor deficiency due to Arg378Cys mutation 335
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight 327
Marcatori di severità di malattia nei soggetti con angioedema da carenza C1 inibitore. 308
Gene regulation in the pathogenesis of angioedema due to inherited c1 inhibitor deficiency (hereditary angioedema) 304
Molecular mechanism for the pathogenicity of the human C1-inhibitor Arg378Cys variant 272
Structural and functional characterization of mutations in C1-ihn responsible for hereditary angioedema 268
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction 264
Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema : functional and structural correlates 244
Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency 235
Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency 228
A SERPING1 variant that causes C1-inhibitor deficiency without hereditary angioedema 226
Identification of variables causing different clinical expression of inherited c1-inh deficiency (hereditary angioedema) 219
Ongoing contact activation in patients with hereditary angioedema 214
Immune response covaries with corticosterone plasma levels under experimentally stressful conditions in nestling barn swallows (Hirundo rustica) 210
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients 199
Optimizing long-term joint health in the treatment of hemophilia 197
Patterns of C1-Inhibitor Plasma Levels and Kinin–Kallikrein System Activation in Relation to COVID-19 Severity 196
A case of remittent C1-inhibitor deficiency 193
Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit 191
Novelties in the diagnosis and treatment of angioedema 189
Complement and contact system activation in acute congestive heart failure patients 187
Catabolism of C1 inhibitor influences the response to replacement therapy in hereditary angioedema 185
Anti-C1-Inhibitor Autoantibody Detection by ELISA 185
Hereditary angioedema due to C1 inhibitor deficiency in Belarus : epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene 180
Two Cases Of Peculiar Hypereosinophilic Syndrome Treated With Mepolizumab 178
C1 esterase inhibitor and the kinin-kallikrein system in COVID-19 176
Secreted phospholipases A2 in hereditary angioedema with C1-inhibitor deficiency 171
Updates on Novel Non-Replacement Drugs for Hemophilia 171
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 145
Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case Series 137
Exploring the prevalence and clinical impact of fibromyalgia syndrome in patients with shoulder diseases: a cross-sectional study 136
Efficacy of Lanadelumab in angioedema due to acquired C1 inhibitor deficiency 123
Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema 123
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 120
Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study 119
Pathophysiology of hereditary angioedema 119
Hereditary Deficiency of C1 Inhibitor and Angioedema 118
Structural and functional characterization of mutations in C1-inh responsible for hereditary angioedema 117
High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin mediated angioedema due to hereditary c1-inhibitor deficiency 109
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 100
Artificial Intelligence for Automated Detection of Joint Bleeding via Ultrasound in Hemophilia: Advancing Standardization 85
Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations 79
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients 73
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization 67
Platelet function abnormalities in acquired hemophilia A 59
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 46
Quantitative multiplex profiling of the complement system to diagnose complement‐mediated diseases 45
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? 36
Development of a portable device for the detection of anti-PEG antibodies in human plasma 1
Totale 9.709
Categoria #
all - tutte 26.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022612 42 30 31 34 41 28 38 47 117 53 29 122
2022/2023786 89 91 78 101 68 130 18 55 92 12 45 7
2023/2024543 19 51 36 35 143 81 16 33 20 19 41 49
2024/20251.433 47 109 21 122 81 79 52 131 157 193 178 263
2025/20263.486 298 220 397 276 316 204 437 104 304 245 461 224
Totale 9.709